SEARCH

SEARCH BY CITATION

References

  • Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Gaffney, P.R., Reese, C.B. & Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Ba. Current Biology, 7, 261269.
  • Alyea, E., Weller, E., Schlossman, R., Canning, C., Webb, I., Doss, D., Mauch, P., Marcus, K., Fisher, D., Freeman, A., Parikh, B., Gribben, J., Soiffer, R., Ritz, J. & Anderson, K. (2001) T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood, 98, 934939.
  • Barlogie, B., Desikan, R., Eddlemon, P., Spencer, T., Zeldis, J., Munshi, N., Badros, A., Zangari, M., Anaissie, E., Epstein, J., Shaughnessy, J., Ayers, D., Spoon, D. & Tricot, G. (2001) Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients. Blood, 98, 492494.
  • Beals, C.R., Sheridan, C.M., Turck, C.W., Gardner, P. & Crabtree, G.R. (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science, 275, 19301934.
  • Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. & Kwak, L.W. (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Medicine, 5, 11711177.
  • Cerwenka, A. & Lanier, L.L. (2001) Natural killer cells, viruses and cancer. Nature Reviews. Immunology, 1, 4149.
  • Chou, M.M., Hou, W., Johnson, J., Graham, L.K., Lee, M.H., Chen, C.S., Newton, A.C., Schaffhausen, B.S. & Toker, A. (1998) Regulation of protein kinase Cz by PI 3-kinase and PDK-1. Current Biology, 8, 10691077.
  • Chow, C.W., Rincon, M. & Davis, R.J. (1999) Requirement for transcription factor NFAT in interleukin-2 expression. Molecular and Cellular Biology, 19, 23002307.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. & Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. The New England Journal of Medicine, 346, 235242.
  • Corral, L.G., Haslett, P.A., Muller, G.W., Chen, R., Wong, L.M., Ocampo, C.J., Patterson, R.T., Stirling, D.I. & Kaplan, G. (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-a. Journal of Immunology, 163, 380386.
  • Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785789.
  • Davies, F.E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.T., Lin, B., Podar, K., Gupta, D., Chauhan, D., Treon, S.P., Richardson, P.G., Schlossman, R.L., Morgan, G.J., Muller, G.W., Stirling, D.I. & Anderson, K.C. (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood, 98, 210216.
  • Dredge, K., Marriott, J.B., Todryk, S.M., Muller, G.W., Chen, R., Stirling, D.I. & Dalgleish, A.G. (2002) Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. Journal of Immunology, 168, 49144919.
  • Franke, T.F., Kaplan, D.R., Cantley, L.C. & Toker, A. (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science, 275, 665668.
  • Galea-Lauri, J., Darling, D., Gan, S.U., Krivochtchapov, L., Kuiper, M., Gaken, J., Souberbielle, B. & Farzaneh, F. (1999) Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. Journal of Immunology, 163, 6270.
  • Geltz, N.R. & Augustine, J.A. (1998) The p85 and p110 subunits of phosphatidylinositol 3-kinase-a are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets. Blood, 91, 930939.
  • Gomez, J., Pitton, C., Garcia, A., Martinez de Aragon, A., Silva, A. & Rebollo, A. (1995) The z isoform of protein kinase C controls interleukin-2-mediated proliferation in a murine T cell line: evidence for an additional role of protein kinase C e and b. Experimental Cell Research, 218, 105113.
  • Gomez, J., Garcia, A.L.R.B., Bonay, P., Martinez, A.C., Silva, A., Fresno, M., Carrera, A.C., Eicher-Streiber, C. & Rebollo, A. (1997) IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-z. Journal of Immunology, 158, 15161522.
  • Gong, J., Koido, S., Chen, D., Tanaka, Y., Huang, L., Avigan, D., Anderson, K., Ohno, T. & Kufe, D. (2002) Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Blood, 99, 25122517.
  • Gupta, D., Treon, S.P., Shima, Y., Hideshima, T., Podar, K., Tai, Y.T., Lin, B., Lentzsch, S., Davies, F.E., Chauhan, D., Schlossman, R.L., Richardson, P., Ralph, P., Wu, L., Payvandi, F., Muller, G., Stirling, D.I. & Anderson, K.C. (2001) Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia, 15, 19501961.
  • Haslett, P.A., Corral, L.G., Albert, M. & Kaplan, G. (1998) Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. Journal of Experimental Medicine, 187, 18851892.
  • Haslett, P.A., Klausner, J.D., Makonkawkeyoon, S., Moreira, A., Metatratip, P., Boyle, B., Kunachiwa, W., Maneekarn, N., Vongchan, P., Corral, L.G., Elbeik, T., Shen, Z. & Kaplan, G. (1999) Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients. AIDS Research and Human Retroviruses, 15, 11691179.
  • Hayashi, T., Hideshima, T., Akiyama, M., Richardson, P., Schlossman, R.L., Chauhan, D., Munshi, N.C., Waxman, S. & Anderson, K.C. (2002) Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment. Molecular Cancer Therapeutics, 1, 851860.
  • Hayashi, T., Hideshima, T. & Anderson, K.C. (2003a) Novel therapies for multiple myeloma. British Journal of Haematology, 120, 1017.
  • Hayashi, T., Hideshima, T., Akiyama, M., Raje, N., Richardson, P., Chauhan, D. & Anderson, K.C. (2003b) Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes. Blood, 102, 14351442.
  • Hayashi, T., Treon, S.P., Hideshima, T., Tai, Y.T., Akiyama, M., Richardson, P., Chauhan, D., Grewal, I.S. & Anderson, K.C. (2003c) Recombinant humanized anti-CD40 monoclonal antibody triggers autologous antibody-dependent cell-mediated cytotoxicity against multiple myeloma cells. British Journal of Haematology, 121, 592596.
  • Hideshima, T. & Anderson, K.C. (2002) Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nature Reviews. Cancer, 2, 927937.
  • Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F.E., Tai, Y.T., Treon, S.P., Lin, B., Schlossman, R.L., Richardson, P., Muller, G., Stirling, D.I. & Anderson, K.C. (2000) Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood, 96, 29432950.
  • Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., Adams, J. & Anderson, K.C. (2002) NF-kB as a therapeutic target in multiple myeloma. Journal of Biological Chemistry, 277, 1663916647.
  • Jiang, K., Zhong, B., Gilvary, D.L., Corliss, B.C., Hong-Geller, E., Wei, S. & Djeu, J.Y. (2000) Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nature Immunology, 1, 419425.
  • Kang, H., Schneider, H. & Rudd, C.E. (2002) Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110. Journal of Biological Chemistry, 277, 912921.
  • LeBlanc, R., Hideshima, T., Catley, L.P., Shringarpure, R., Burger, R., Mitsiades, N., Mitsiades, C., Cheema, P., Chauhan, D., Richardson, P.G., Anderson, K.C. & Munshi, N.C. (2004) Immunomodulatory drug costimulates T cells via the B7-CD28 pathway. Blood, 103, 17871790.
  • Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L. & Verdonck, L.F. (1997) Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 42064211.
  • Macian, F., Lopez-Rodriguez, C. & Rao, A. (2001) Partners in transcription: NFAT and AP-1. Oncogene, 20, 24762489.
  • Marriott, J.B., Clarke, I.A., Dredge, K., Muller, G., Stirling, D. & Dalgleish, A.G. (2002) Thalidomide and its analogues have distinct and opposing effects on TNF-a and TNFR2 during co-stimulation of both CD4+ and CD8+ T cells. Clinical and Experimental Immunology, 130, 7584.
  • van Mierlo, G.J., den Boer, A.T., Medema, J.P., der Voort, E.I., Fransen, M.F., Offringa, R., Melief, C.J. & Toes, R.E. (2002) CD40 stimulation leads to effective therapy of CD40 tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proceedings of the National Academy of Sciences of the United States of America, 99, 55615566.
  • Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Richardson, P.G., Hideshima, T., Munshi, N.C., Treon, S.P. & Anderson, K.C. (2002a) Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood, 99, 45254530.
  • Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Richardson, P.G., Hideshima, T., Munshi, N., Treon, S.P. & Anderson, K.C. (2002b) Biologic sequelae of nuclear factor-kB blockade in multiple myeloma: therapeutic applications. Blood, 99, 40794086.
  • Moller, D.R., Wysocka, M., Greenlee, B.M., Ma, X., Wahl, L., Flockhart, D.A., Trinchieri, G. & Karp, C.L. (1997) Inhibition of IL-12 production by thalidomide. Journal of Immunology, 159, 51575161.
  • Podar, K., Tai, Y.T., Davies, F.E., Lentzsch, S., Sattler, M., Hideshima, T., Lin, B.K., Gupta, D., Shima, Y., Chauhan, D., Mitsiades, C., Raje, N., Richardson, P. & Anderson, K.C. (2001) Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood, 98, 428435.
  • Rajkumar, S.V., Hayman, S., Gertz, M.A., Dispenzieri, A., Lacy, M.Q., Greipp, P.R., Geyer, S., Iturria, N., Fonseca, R., Lust, J.A., Kyle, R.A. & Witzig, T.E. (2002) Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. Journal of Clinical Oncology, 20, 43194323.
  • Reif, K., Burgering, B.M. & Cantrell, D.A. (1997) Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. Journal of Biological Chemistry, 272, 1442614433.
  • Reynolds, C., Ratanatharathorn, V., Adams, P., Braun, T., Silver, S., Ayash, L., Carson, E., Eisbruch, A., Dawson, L.A., McDonagh, K., Ferrara, J. & Uberti, J. (2001) Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma. Bone Marrow Transplantation, 27, 801807.
  • Richardson, P., Jagannath, S., Schlossman, R., Weller, E., Zeldenrust, S., Rajumar, V., Alsina, M., Desikan, K.R., Mitsiades, C., Kelly, K., Doss, D., McKenney, M., Shepard, T., Rich, R., Warren, D., Freeman, A., Deocampo, R., Doucet, K., Knight, A.R., Balinski, K., Zeldis, J., Dalton, W.S., Hideshima, T. & Anderson, K.C. (2002a) A multi-center, randomized, phase II study to evaluate the efficacy and safety of two CDC-5013 dose regimens when used alone or combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma. Blood, 100, 104a105a (abstract).
  • Richardson, P.G., Schlossman, R.L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L.P., Doss, D., Kelly, K., McKenney, M., Mechlowicz, J., Freeman, A., Deocampo, R., Rich, R., Ryoo, J.J., Chauhan, D., Balinski, K., Zeldis, J. & Anderson, K.C. (2002b) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood, 100, 30633067.
  • Schafer, P.H., Gandhi, A.K., Loveland, M.A., Chen, R.S., Man, H.W., Schnetkamp, P.P., Wolbring, G., Govinda, S., Corral, L.G., Payvandi, F., Muller, G.W. & Stirling, D.I. (2003) Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. Journal of Pharmacology and Experimental therapeutics, 305, 12221232.
  • Takahashi, T., Makiguchi, Y., Hinoda, Y., Kakiuchi, H., Nakagawa, N., Imai, K. & Yachi, A. (1994) Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. Journal of Immunology, 153, 21022109.
  • Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., den Driesch, P., Brocker, E.B., Steinman, R.M., Enk, A., Kampgen, E. & Schuler, G. (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. Journal of Experimental Medicine, 190, 16691678.
  • Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. & Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology, 108, 805816.
  • Treon, S.P., Pilarski, L.M., Belch, A.R., Kelliher, A., Preffer, F.I., Shima, Y., Mitsiades, C.S., Mitsiades, N.S., Szczepek, A.J., Ellman, L., Harmon, D., Grossbard, M.L. & Anderson, K.C. (2002) CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. Journal of Immunotherapy, 25, 7281.
  • Trotta, R., Puorro, K.A., Paroli, M., Azzoni, L., Abebe, B., Eisenlohr, L.C. & Perussia, B. (1998) Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. Journal of Immunology, 161, 66486656.
  • Wen, Y.J., Min, R., Tricot, G., Barlogie, B. & Yi, Q. (2002) Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood, 99, 32803285.
  • Wymann, M.P. & Pirola, L. (1998) Structure and function of phosphoinositide 3-kinases. Biochimica et Biophysica Acta, 1436, 127150.